Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation

Caspases in Cell Death, Inflammation, and Gasdermin-Induced Pyroptosis

(2020) Sannula Kesavardhana et al.   Annual Review of Immunology

Statin ameliorates adipose inflammation via NLRP3 suppression

(2020) Min Tong et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages

(2020) Qin Fei et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload

(2020) Junyan Wang et al.   Cell Death & Disease

Computationally modeling mammalian succinate dehydrogenase kinetics identifies the origins and primary determinants of ROS production

(2020) Neeraj Manhas et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NLRP3 inflammasome in endothelial dysfunction

(2020) Baochen Bai et al.   Cell Death & Disease

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

(2019) Yang Yang et al.   Cell Death & Disease

Coronary Microvascular Dysfunction

(2019) Thomas H. Schindler et al.   JACC-Cardiovascular Imaging

NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy

(2019) Negin Parsamanesh et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation

(2019) Chang Jia et al.   Cell Death & Disease

Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells

(2018) Ao Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation

(2018) Chunxia Yao et al.   CIRCULATION

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

(2018) Alena Grebe et al.   CIRCULATION RESEARCH

Coronary microembolization and microvascular dysfunction

(2018) Gerd Heusch et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome

(2018) Soichi Sano et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Succinate Dehydrogenase Complex: An Updated Review

(2018) Mohamed Rizwan Haroon Al Rasheed et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension

(2018) Shalini M Krishnan et al.   CARDIOVASCULAR RESEARCH

Progressive waves of IL-1β release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways

(2018) Claudia Semino et al.   Cell Death & Disease

Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials

(2017) Suzanne de Waha et al.   EUROPEAN HEART JOURNAL

Metabolic regulation of NLRP3

(2017) Mark M. Hughes et al.   IMMUNOLOGICAL REVIEWS

Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNF α in Vascular Endothelial Cells through a PXR-Dependent Mechanism

(2017) Shaolan Wang et al.   MOLECULAR PHARMACOLOGY

The NLRP3 inflammasome in acute myocardial infarction

(2017) Stefano Toldo et al.   Nature Reviews Cardiology

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Establishment of a Novel Mouse Model of Coronary Microembolization

(2016) Ju-Ying Qian et al.   CHINESE MEDICAL JOURNAL

Coronary microvascular obstruction in acute myocardial infarction

(2015) Giampaolo Niccoli et al.   EUROPEAN HEART JOURNAL

Mitochondria in the Regulation of Innate and Adaptive Immunity

(2015) Samuel E. Weinberg et al.   IMMUNITY

Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies

(2015) Mark A. Marinescu et al.   JACC-Cardiovascular Imaging

TNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs

(2014) Zhang-Wei Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cardiovascular remodelling in coronary artery disease and heart failure

(2014) Gerd Heusch et al.   LANCET

Coronary microvascular dysfunction: mechanisms and functional assessment

(2014) Paolo G. Camici et al.   Nature Reviews Cardiology

Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release

(2014) Dmitry B. Zorov et al.   PHYSIOLOGICAL REVIEWS

NLRP3 in myocardial ischaemia-reperfusion injury: inflammasome-dependent or -independent role in different cell types

(2013) M. Takahashi   CARDIOVASCULAR RESEARCH

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

(2013) Øystein Sandanger et al.   CARDIOVASCULAR RESEARCH

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin

(2013) Mamoru Satoh et al.   CLINICAL SCIENCE

Effect of Atorvastatin (Lipitor) on Myocardial Apoptosis and Caspase-8 Activation Following Coronary Microembolization

(2011) Lang Li et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse

(2011) E. Mezzaroma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A role for mitochondria in NLRP3 inflammasome activation

(2010) Rongbin Zhou et al.   NATURE

Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction

(2009) M. L. Fokkema et al.   EUROPEAN HEART JOURNAL